Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae.
Ayerbe-Algaba R, Gil-Marqués ML, Jiménez-Mejías ME, Sánchez-Encinales V, Parra-Millán R, Pachón-Ibáñez ME, Pachón J, Smani Y. Ayerbe-Algaba R, et al. Front Cell Infect Microbiol. 2018 Oct 3;8:348. doi: 10.3389/fcimb.2018.00348. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 30338245 Free PMC article.
Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
Pachón-Ibáñez ME, Docobo-Pérez F, López-Rojas R, Domínguez-Herrera J, Jiménez-Mejias ME, García-Curiel A, Pichardo C, Jiménez L, Pachón J. Pachón-Ibáñez ME, et al. Antimicrob Agents Chemother. 2010 Mar;54(3):1165-72. doi: 10.1128/AAC.00367-09. Epub 2010 Jan 4. Antimicrob Agents Chemother. 2010. PMID: 20047914 Free PMC article.
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
Bernabeu-Wittel M, Pichardo C, García-Curiel A, Pachón-Ibáñez ME, Ibáñez-Martínez J, Jiménez-Mejías ME, Pachón J. Bernabeu-Wittel M, et al. Clin Microbiol Infect. 2005 Apr;11(4):319-25. doi: 10.1111/j.1469-0691.2005.01095.x. Clin Microbiol Infect. 2005. PMID: 15760430 Free article.
Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
Parra Millán R, Jiménez Mejías ME, Sánchez Encinales V, Ayerbe Algaba R, Gutiérrez Valencia A, Pachón Ibáñez ME, Díaz C, Pérez Del Palacio J, López Cortés LF, Pachón J, Smani Y. Parra Millán R, et al. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4464-70. doi: 10.1128/AAC.02708-15. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27161639 Free PMC article.
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A, Vila-Domínguez A, Caretero-Ledesma M, Ayerbe-Algaba R, Pachón J, Jiménez-Mejías ME, Smani Y. Miró-Canturri A, et al. Among authors: jimenez mejias me. Microbiol Spectr. 2021 Oct 31;9(2):e0040321. doi: 10.1128/Spectrum.00403-21. Epub 2021 Oct 20. Microbiol Spectr. 2021. PMID: 34668743 Free PMC article.
106 results